title: Malignant melanoma--clinical development of peptide-based melanoma vaccines.
authors.affiliation: Medizinische Klinik III, Hematology, Oncology, and Transfusion Medicine, Charité, Campus Benjamin Franklin, Berlin, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Schmittel
authors.forename: Carmen
authors.initials: C
authors.lastname: Scheibenbogen
authors.forename: Anne
authors.initials: A
authors.lastname: Letsch
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Asemissen
authors.forename: Eckhard
authors.initials: E
authors.lastname: Thiel
authors.forename: Ulrich
authors.initials: U
authors.lastname: Keilholz
mesh_terms: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D006801:Humans; D008545:Melanoma / Q000517:prevention & control*; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins / Q000276:immunology*; D010446:Peptide Fragments / Q000276:immunology*; D012878:Skin Neoplasms / Q000517:prevention & control*
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D010446:Peptide Fragments